Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 9, 2016, pp. 1909-1914
Bioline Code: pr16252
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 9, 2016, pp. 1909-1914
© Copyright 2016 - Tropical Journal of Pharmaceutical Research
Oral thearubigins do not protect against acetaminopheninduced hepatotoxicity in mice|
Murad, Hussam AS.; Habib, Hamid SA.; Kamel, Yasser M.; Alsayed, Salah A.; Ali, Soad S. & Gazzaz, Zohair G.
Purpose: To investigate the potential protective effect of oral repeated doses of thearubigins against
acetaminophen-induced hepatotoxicity in mice.
Methods: Mice were randomly divided into six groups (n=8) and administered the following: Control
group (saline), acetaminophen group (saline), N-acetylcysteine group (500 mg/kg/day), and
thearubigins groups (60, 70, 100 mg/kg/day). The drugs were given orally by gavage for seven days. On
day 7, 1 h after the last dose of treatment, the mice (except control group) were given a single dose of
acetaminophen (n-acetyl-p-aminophenol, APAP) orally by gavage (350 mg/kg) and then sacrificed 4 h
post-APAP intake. Blood was collected for biochemical measurements and their liver were subjected to
biochemical and histopathological assessment.
Results: The acetaminophen group showed significant increases (p < 0.001) in serum alanine
aminotransferase level, hepatic cytochrome P2E1 level, and serum and hepatic malondialdehyde levels.
Moreover it showed significant decrease (p < 0.001) in serum and hepatic glutathione levels.
Morphologically, the liver sections showed cellular necrosis, vacuolization, and degeneration around the
centrilobular veins. Pretreatment with N-acetylcysteine reversed all acetaminophen-induced changes (p
< 0.001 for all biomarkers except for hepatic MDA (p = 0.014) while pretreatment with thearubigins
failed to reverse any of them.
Conclusion: Oral repeated doses of thearubigins failed to protect against acetaminophen-induced
hepatotoxicity in mice and didn\'t affect hepatic cytochrome P2E1 level.
Acetaminophen, Hepatotoxicity; Thearubigins; N-acetylcysteine; Cellular necrosis; Vacuolization; Hepatic cytochrome P2E1
Alternative site location: http://www.tjpr.org